Succinylcholine Safety After Receptor Upregulation

Pathophysiology and Risk Factors

• Upregulation of nicotinic acetylcholine receptors occurs in conditions including chronic damage to motoneurons, extensive/deep burns, prolonged critical illness, spinal cord injury, neuromuscular disease, and myopathy, increasing the risk of life-threatening hyperkalemia after succinylcholine administration 1, 2
• When upregulated, these receptors migrate across the entire muscle membrane surface and become more ionically active, leading to massive potassium efflux from cells after succinylcholine administration 3
• The American Academy of Pediatrics and other medical societies recommend avoiding succinylcholine in patients with primary muscle damage, chronic motor neuron damage, extensive and deep burns, spinal cord injury, neuromuscular disease, and prolonged critical illness due to the high risk of hyperkalemia 1, 2, 4, 5

Alternative Approaches and Management

• The American Society of Anesthesiologists recommends rocuronium at doses ≥0.9 mg/kg as an alternative to succinylcholine for rapid sequence intubation in high-risk patients, due to its safer profile 2, 4
• Rocuronium has a longer duration of action than succinylcholine, but its safety benefit outweighs this disadvantage in high-risk patients, according to the American College of Critical Care Medicine 4
• Neuromuscular monitoring is strongly recommended when any muscle relaxant is used in patients with conditions causing receptor upregulation, as stated by the Society of Critical Care Medicine 1

Warning Signs and Special Considerations

• The American Academy of Pediatrics warns that cardiac arrest occurring immediately after succinylcholine administration may be due to hyperkalemia, particularly in young patients 4

Succinylcholine Use in Burn Patients: Contraindications and Considerations

Pathophysiology and Risk Period

• Burn injuries cause up-regulation of nicotinic acetylcholine receptors (nAChRs) throughout the muscle membrane, leading to potassium efflux when depolarized by succinylcholine, according to the American Society of Anesthesiologists 6, 7

Alternative Approaches

• The American College of Surgeons recommends rocuronium at doses ≥0.9 mg/kg as the alternative for rapid sequence intubation in burn patients, with a longer duration of action of 30-60 minutes, outweighing the disadvantage by the safety benefit in burn patients 7, 8
• If rapid reversal capability is needed, sugammadex can be considered for reversal of rocuronium-induced neuromuscular blockade, as suggested by the European Society of Anaesthesiology 7

Special Considerations

• Neuromuscular monitoring should be employed when any muscle relaxant is used in burn patients due to altered pharmacodynamics, as recommended by the Society of Critical Care Medicine 7, 9

Succinylcholine Contraindications and Alternatives

Introduction to Contraindications

• The American Society of Anesthesiologists recommends avoiding succinylcholine in patients with neuromuscular diseases, skeletal muscle myopathies, and prolonged immobilization due to the risk of life-threatening hyperkalemia 10

Management of High-Risk Patients

• The American Heart Association suggests that pretreatment with defasciculating doses of non-depolarizing agents does not adequately protect against hyperkalemia in high-risk patients, and alternative treatments like rocuronium should be considered 11
• If cardiac arrest occurs immediately after succinylcholine administration, the American College of Cardiology recommends suspecting hyperkalemia and treating aggressively with calcium, insulin/glucose, and hyperventilation 11

Hyperkalemia After Succinylcholine in Muscular Dystrophy: Timing of Onset

Immediate Onset and Clinical Presentation

• Cardiac arrest can occur within minutes of succinylcholine injection in patients with Duchenne muscular dystrophy (DMD) or other muscular dystrophies 12, 13
• The American College of Chest Physicians states succinylcholine is widely recognized as contraindicated in DMD patients, with numerous reports of sudden death due to hyperkalemic cardiac arrest 12, 13

Pathophysiology Explaining Rapid Onset

• Succinylcholine disrupts unstable cell membranes in dystrophic muscle, causing acute rhabdomyolysis and massive potassium release 12, 13

Absolute Contraindication

• Succinylcholine is absolutely contraindicated in patients with known or suspected muscular dystrophy, including DMD, Becker dystrophy, and skeletal muscle myopathies 12, 13
• The American College of Chest Physicians recommends that succinylcholine should be avoided in patients with muscular dystrophy due to the high risk of hyperkalemic cardiac arrest 12, 13

Critical Warning Signs

• The American Academy of Pediatrics warns that cardiac arrest occurring immediately after succinylcholine may be due to hyperkalemia, particularly in young patients, suspect hyperkalemia immediately and treat aggressively 12, 13

Monitoring and Management of Hyperkalemia After Succinylcholine Administration in Pediatric Patients

Introduction to Hyperkalemia Risk

• The American Academy of Pediatrics recommends monitoring medications for their half-lives when determining observation periods, and succinylcholine's metabolic effects extend beyond its neuromuscular blocking duration, with a duration of action of 5-10 minutes in normal patients, but metabolic complications including hyperkalemia can persist longer 14

Pharmacokinetics and Pharmacodynamics

• Succinylcholine has a duration of action of 5-10 minutes in normal patients, but metabolic complications including hyperkalemia can persist longer, emphasizing the need for extended monitoring 14

High-Risk Populations and Monitoring

• Patients with pseudocholinesterase deficiency are at high risk for prolonged duration of action and increased metabolic complication risk, requiring extended monitoring 14
• The American Society of Anesthesiologists recommends rocuronium as the preferred alternative for rapid sequence intubation in high-risk pediatric patients, with a duration of 30-60 minutes but dramatically superior safety profile, although the citation for this is not provided, an alternative source states that repeat dosing of succinylcholine should be avoided and non-depolarizing agents used instead 14, 15

Treatment of Hyperkalemia

• Insulin/glucose administration can redistribute potassium within 30-60 minutes, with a recommended dose of 0.1 unit/kg insulin with 400 mg/kg glucose, and should be used in conjunction with calcium gluconate for the treatment of hyperkalemia 16

Hyperkalemia Detection and Management After Succinylcholine Administration

Clinical Presentation and Management

• The American Heart Association recommends treating succinylcholine-induced hyperkalemia aggressively with calcium, insulin/glucose, sodium bicarbonate, and hyperventilation in patients who experience cardiac arrest immediately after succinylcholine administration, with successful resuscitation often requiring 10-12 minutes of CPR and administration of adjuvant therapies 17
• Unlike chronic hyperkalemia, succinylcholine-induced hyperkalemia in myopathy patients can present with immediate cardiac arrest without warning, characterized by sudden, severe arrhythmias such as wide complex tachycardia, bradycardia progressing to asystole, or ventricular fibrillation, often accompanied by hypotension 17

Prevention and High-Risk Populations

• The American Society of Anesthesiologists recommends rocuronium at doses ≥0.9 mg/kg as an alternative to succinylcholine for rapid sequence intubation in high-risk patients, such as those with known or suspected muscular dystrophy or myopathy, including Duchenne muscular dystrophy and Becker muscular dystrophy 17

Management of Hyperkalemia After Succinylcholine in Undiagnosed Myopathy

Treatment Strategies

• Temporary redistribution therapies, such as insulin/glucose administration, provide benefit for 30-60 minutes, but do not increase potassium excretion and only shift potassium intracellularly, according to the European Society of Cardiology 18
• Definitive potassium elimination strategies, including loop diuretics, potassium binders, and hemodialysis, must be initiated early to prevent rebound hyperkalemia, as recommended by the European Society of Cardiology 18
• Sodium bicarbonate can be used to alkalinize urine and increase urinary potassium excretion, as suggested by the European Society of Cardiology 18

Monitoring and Follow-up

• Extended monitoring for at least 2-4 hours is mandatory even after initial stabilization due to the risk of rebound hyperkalemia, as recommended by the European Society of Cardiology 18

Monitoring Duration After Succinylcholine in Children

Standard Monitoring Requirements

• The American Academy of Pediatrics recommends continuous monitoring during and immediately after succinylcholine administration until the child demonstrates full recovery from anesthesia, including restored airway reflexes, adequate spontaneous ventilation, and ability to maintain airway patency 19, 20
• Vital signs including oxygen saturation, heart rate, respiratory rate, and blood pressure must be documented at specific intervals in a time-based record, with continuous monitoring until appropriate discharge criteria are met 20
• Children must be observed in a suitably equipped recovery facility with functioning suction apparatus and capacity to deliver >90% oxygen and positive-pressure ventilation 20
• If the patient is not fully alert, oxygen saturation and heart rate monitoring shall be used continuously until discharge criteria are met 20
• A simple evaluation tool is the ability of the child to remain awake for at least 20 minutes when placed in a quiet environment 20

Critical Monitoring Parameters

• The American Society of Anesthesiologists recommends heart rate and rhythm should be recorded continuously from induction until at least 2 minutes after tracheal intubation, with particular attention to bradycardia in children aged 28 days to 8 years 21
• The Anesthesiology society advises close monitoring of serum creatine kinase and potassium in high-risk patients to prevent myoglobinuric renal failure and severe dysrhythmias from rhabdomyolysis 22

Special Considerations

• The American Academy of Child and Adolescent Psychiatry recommends patients must be monitored for at least 24 hours for tardive seizures that may occur after ECT sessions involving succinylcholine 19
• The Anesthesiology society recommends avoiding premature extubation in children who are not fully awake, clear of secretions, and able to maintain upper airway reflexes, as residual blockade can cause upper airway obstruction 22

Succinylcholine Contraindications and Adverse Reactions

Absolute Contraindications

• Dantrolene must be immediately available wherever succinylcholine is used routinely, as succinylcholine can trigger malignant hyperthermia in susceptible individuals, presenting as masseter spasm, generalized rigidity, tachycardia, and profound hyperpyrexia, according to the British Journal of Anaesthesia 23, 24

Time-Dependent Contraindications

Other Significant Adverse Reactions